4.6 Review

New Drugs Approved in 2020

Journal

AMERICAN JOURNAL OF MEDICINE
Volume 134, Issue 9, Pages 1096-1100

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2021.03.034

Keywords

Accelerated approval; Fast track; Novel drugs; Priority review; US Food and Drug Administration

Ask authors/readers for more resources

In 2020, the US Food and Drug Administration approved 53 novel drugs, with the majority being reviewed and approved through an expedited review pathway, and over half being approved for the treatment of rare diseases.
In 2020, the US Food and Drug Administration approved 53 novel drugs. Thirty-six of the 53 (68%) drugs were reviewed and approved through an expedited review pathway, and 31 of the 53 (58%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the US Food and Drug Administration in 2020. (C) 2021 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available